Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Economic Evaluation in Genomic and Precision Medicine

BUCHANAN J., (2023)

Retrospective file review shows limited genetic services fails most patients – an argument for the implementation of exome sequencing as a first-tier test in resource-constraint settings

Wiener EK. et al, (2023), Orphanet Journal of Rare Diseases, 18

Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.

Liao W. et al, (2023), Lancet Respir Med

Introduction to economic evaluation in health sciences

Mitropoulou C. et al, (2023), Economic Evaluation in Genomic and Precision Medicine, 1 - 14

Preface

Mitropoulou C. et al, (2023), Economic Evaluation in Genomic and Precision Medicine, xiii - xiv

Using “big data” for economic evaluations in genomics

Wordsworth S. et al, (2023), Economic Evaluation in Genomic and Precision Medicine, 113 - 121

Resource allocation in genetic and genomic medicine.

Buchanan J. et al, (2022), J Community Genet, 13, 463 - 466

Eliciting risk preferences that predict risky health behavior: A comparison of two approaches.

Yang M. et al, (2022), Health Econ, 31, 836 - 858

Factor's that impact on women's decision-making around prenatal genomic tests: An international discrete choice survey.

Buchanan J. et al, (2022), Prenat Diagn

Women's preferences for receiving uncertain results from prenatal genomic testing: An international discrete choice experiment

Lewis C. et al, (2022), EUROPEAN JOURNAL OF HUMAN GENETICS, 30, 53 - 53

Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options Article

Koleva-Kolarova R. et al, (2022), Applied Health Economics and Health Policy

Defining a Core Data Set for the Economic Evaluation of Precision Oncology.

Pollard S. et al, (2022), Value Health

Assessing women’s preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design

Hammond J. et al, (2022), PLOS ONE, 17, e0261898 - e0261898

Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol

Lewis C. et al, (2021), NIHR Open Research, 1, 23 - 23

Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol

Lewis C. et al, (2021), NIHR Open Research, 1, 23 - 23

Development of an intervention to support the implementation of evidence-based strategies for optimising antibiotic prescribing in general practice.

Borek AJ. et al, (2021), Implement Sci Commun, 2

Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: a choice experiment

MORRELL E., (2021), PLoS Medicine

What aspects of illness influence public preferences for healthcare priority setting? A discrete choice experiment in the UK

MORRELL E. et al, (2021), PharmacoEconomics

Cost-effectiveness of amphotericin B deoxycholate versus itraconazole for induction therapy of talaromycosis in HIV-infected adults in Vietnam

BUCHANAN J. et al, (2021), Open Forum Infectious Diseases

Correction to: Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

Pollard S. et al, (2021), Eur J Hum Genet

Load More

Include forthcoming?